Yuyan Jin
Company: SanegeneBio
Job title: Senior Vice President & Head of Nonclincial & Clinical Development
Seminars:
Reviewing the Advancements of siRNA-based Therapeutics to Treat Complement-Mediated Kidney Disease 10:00 am
Highlighting the potential of RNA interference-based therapeutics in modulating complement-driven kidney diseases and offer insights into their mechanism of action Exploring the unique advantages of siRNA technology for complement inhibition in kidney disease, such as potentially targeted delivery and sustained effect Touching upon challenges and best practices in conducting large Phase 3 trialsRead more
day: Conference Day One
Panel Discussion: Navigating the Clinical Challenges as Complement Inhibitors are Applied to Larger Patient Populations 10:30 am
Discussing the critical considerations for managing systemic complement inhibition and minimizing off-target effects and infection risks in a diverse patient cohort Overcoming diagnostic and biomarker limitations to accurately identify which patients within larger populations will truly benefit from complement inhibition Exploring innovative drug delivery modalities are essential to improve patient convenience and adherence for chronic…Read more
day: Conference Day One